Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome

Osteoporosis International

Volumn 18, Issue 10, 2007, Pages 1363-1370

  Yarom, N ^a,b   Yahalom, R ^b   Shoshani, Y ^b   Hamed, W ^c   Regev, E ^c   Elad, S ^c  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Alendronate; Bisphosphonate; Jaws; Osteomyelitis; Osteonecrosis; Osteoporosis

Indexed keywords

ALENDRONIC ACID; AMOXICILLIN; BISPHOSPHONIC ACID DERIVATIVE; DOXYCYCLINE;

ADULT; AGED; ARTICLE; BONE NECROSIS; CANCER; CANCER PATIENT; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DENTAL SURGERY; DENTURE; DISEASE PREDISPOSITION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW; MAJOR CLINICAL STUDY; MANDIBLE RESECTION; MORBIDITY; PRIORITY JOURNAL; SMOKING; TREATMENT OUTCOME;

AGED; BONE DENSITY CONSERVATION AGENTS; DENTAL CARE; DIPHOSPHONATES; FEMALE; HUMANS; JAW DISEASES; MIDDLE AGED; OSTEONECROSIS; OSTEOPOROSIS; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SMOKING; TREATMENT OUTCOME;

EID: 34548547442     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-007-0384-2     Document Type: Article

References (28)

1. Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115-1117
2. Wang J, Goodger NM, Pogrel MA (2003) Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61:1104-1107
3. Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63:1567-1575
4. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62:527-534
5. Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C (2006) Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope 116:115-120
6. Migliorati CA, Schubert MM, Peterson DE, Seneda LM (2005) Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 104:83-93
7. Purcell PM, Boyd IW (2005) Bisphosphonates and osteonecrosis of the jaw. Med J Aust 182:417-418
8. Shlomi B, Levy Y, Kleinman S, Better H, Kahn A, Shtabsky A, Chaushu G (2005) Avascular necrosis of the jaw bone after bisphosphonate therapy. Harefuah 144:536-539, (in Hebrew)
9. Migliorati CA, Casiglia J, Epstein J, Jacobsen PL, Siegel MA, Woo SB (2005) Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J Am Dent Assoc 136:1658-1668
10. Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD (1996) Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group. N Engl J Med 334:488-493
11. Durie BG, Katz M, Crowley J (2005) Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353:99-102
12. Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA (2005) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates:incidence and risk factors. J Clin Oncol 23:8580-8587
13. Hoff AO, Toth B, Altundag K, Guarneri V, Nooka A, Desrouleaux K, Klein M, Adamus A, Sayegh G, Worthing A, Gagel RF, Hortobagyi GN (2005) Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. The 27th Annual Meeting of the American Society for Bone and Mineral Research; Abstract 1218
14. Sambrook P, Cooper C (2006) Osteoporosis. Lancet 367:2010-2018
15. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761-1767
16. Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C (2002) Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:570-578
17. Close P, Neuprez A, Reginster JY (2006) Developments in the pharmacotherapeutic management of osteoporosis. Expert Opin Pharmacother 7:1603-1615
18. American Dental Association Council on Scientific Affairs (2006) Dental management of patients receiving oral bisphosphonate therapy: Expert panel recommendations. J Am Dent Assoc 137:1144-1150
19. Emkey RD Ettinger M (2006) Improving compliance and persistence with bisphosphonate therapy for osteoporosis. Am J Med 119:S18-S24
20. Solomon CG (2002) Bisphosphonates and osteoporosis. N Engl J Med 346:642
21. Hjorting-Hansen E (1970) Decortication in treatment of osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol 29:641-655
22. Baltensperger M, Gratz K, Bruder E, Lebeda R, Makek M, Eyrich G (2004) Is primary chronic osteomyelitis a uniform disease? Proposal of a classification based on a retrospective analysis of patients treated in the past 30 years. J Craniomaxillofac Surg 32:43-50
23. Hansen T, Kunkel M, Weber A, James Kirkpatrick C (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155-160
24. Tada A, Senpuku H, Motozawa Y, Yoshihara A, Hanada N, Tanzawa H (2006) Association between commensal bacteria and opportunistic pathogens in the dental plaque of elderly individuals. Clin Microbiol Infect 12:776-781
25. Levin L, Herzberg R, Dolev E, Schwartz-Arad D (2004) Smoking and complications of onlay bone grafts and sinus lift operations. Int J Oral Maxillofac Implants 19:369-373
26. Schwartz-Arad D, Samet N, Samet N, Mamlider A (2002) Smoking and complications of endosseous dental implants. J Periodontol 73:153-157
27. Chapurlat RD, Delmas PD (2006) Drug insight: Bisphosphonates for postmenopausal osteoporosis. Nat Clin Pract Endocrinol Metab 2:211-219
28. Elad S, Yarom N, Hamed W, Ayalon S, Yahalom R, Regev E (2006) Osteomylelitis and necrosis of the jaw in patients treated with bisphosphonates. A comparative study. Clin Lab Haematol 28:393-398